IMPACT Medicom

Lung Cancer Screening: Ontario

September 02, 2021
IMPACT Medicom
Lung Cancer Screening: Ontario
Show Notes

Background

  • Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) 
  • Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer cases in Canada are stage 4 at diagnosis. (2020 Canadian Cancer Statistics) 
  • Two clinical trials, the Dutch-Belgian screening trial (NELSON) and the United States National Lung Screening Trial (NLST), have demonstrated the value of lung cancer screening in reducing mortality rates in high-risk populations. 
  • The lung cancer community across Canada is therefore united in the belief that screening programs should be implemented nationwide. 
  • Lung Cancer Screening programs have been announced across Canada. The Ontario program launched in April 2021 and the program in Quebec launched in June 2021. A program in BC was announced in 2020 and will launch in the near future. Other provinces across Canada are working on developing screening programs also. 
  • In this podcast series, we discuss the importance of lung cancer screening and aim to raise awareness of these programs in Canada in order to improve patient care. 

Our Guests
Dr. Donna Maziak:
Thoracic surgeon and surgical oncologist at the Ottawa Hospital, Ottawa, Ontario.
  
Chantal Bornais:
Nurse navigator at the Ottawa Hospital, Ottawa, Ontario. 


Resources
Lakeridge Health in Oshawa: https://www.lakeridgehealth.on.ca/en/central-east-regional-cancer-program/lung-cancer-screening-pilot.asp

TO FIND A SCREENING PROGRAM NEAR YOU: https://right2survive.ca/resource-centre/screening/

 If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.